Pre-clinical CRC models indicate that TLR4 has both pro- and anti- tumor roles, with expression sites being a possible differentiating factor between whether TLR4 aids in cancer destruction or survival (Li et al. 2017). The gene discussed is TLR4; the disease is colorectal carcinoma.